MinervaX (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Registration number:
32673287
Business model:
B2B
Investors:
we tracked 5 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 4 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

MinervaX is developing a GBS vaccine for maternal immunization, likely to have superior characteristics compared with other GBS vaccine candidates in development.

Companies with similar profile to MinervaX:

CompanyCriteria
Denmark NMD Pharma
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
56%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sunstone Capital, SEED Capital
  • Total raised in a similar range: 10M+ USD
Denmark Particle 3D
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: PreSEED Ventures
Denmark Antag
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Sweden Merozyne Therapeutics
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Orphazyme
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Sweden AMRA
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
Denmark Acarix
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital, SEED Capital
  • Total raised in a similar range: 10M+ USD
Norway Mentis Cura
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Oncoinvent
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden ITBMed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland TILT Biotherapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Mobidiag
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark YourSecondDoctor
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: PreSEED Ventures
Denmark DrugStars
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: SEED Capital